Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · IEX Real-Time Price · USD
+0.030 (2.70%)
At close: May 17, 2024, 4:00 PM
+0.010 (0.88%)
Pre-market: May 20, 2024, 7:32 AM EDT

Bionano Genomics Revenue

Bionano Genomics had revenue of $37.47M in the twelve months ending March 31, 2024, with 26.93% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $8.77M with 18.26% year-over-year growth. In the year 2023, Bionano Genomics had annual revenue of $36.12M with 29.90% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
76.22M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 202336.12M8.31M29.90%
Dec 31, 202227.80M9.82M54.62%
Dec 31, 202117.98M9.48M111.47%
Dec 31, 20208.50M-1.63M-16.06%
Dec 31, 201910.13M-1.87M-15.59%
Dec 31, 201812.00M2.50M26.26%
Dec 31, 20179.51M2.71M39.93%
Dec 31, 20166.79M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MDxHealth 75.33M
Neuronetics 73.23M
Atara Biotherapeutics 34.70M
Cryo-Cell International 31.37M
Jaguar Health 10.14M
BioXcel Therapeutics 1.76M
Revenue Rankings